ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.47
(
0.28%
)
US Tech 100
15,700.80
(
0.54%
)
S&P 500
4,604.37
(
0.41%
)
US Dollar vs CAD
1.35945
(
0.0%
)
Bitcoin
43,988.29
(
-0.44%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Viatris Inc (VTRS)

  7. Viatris Inc (VTRS) News

VTRS Viatris Inc

9.83
0.07 (0.72%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.07 0.72% 9.83 17:56:35
Open Price Low Price High Price Close Price Previous Close
9.77 9.74 9.92 9.83 9.76
more quote information »

Recent News

Date Time Source Heading
11/24/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/24/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/24/202312:02EDGAR2Form 144 - Report of proposed sale of securities
11/14/202307:00PRNUSViatris to Participate in the Jefferies London Healthcare..
11/13/202307:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
11/07/202315:39EDGAR2Form 8-K - Current report
11/07/202315:02PRNUSViatris Reports Strong Financial and Operational Results for..
11/03/202315:36EDGAR2Form ARS - Annual Report to Security Holders
11/03/202315:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202315:31EDGAR2Form DEF 14A - Other definitive proxy statements
10/30/202308:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
10/24/202315:32EDGAR2Form 8-K - Current report
10/24/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
10/23/202308:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
10/20/202316:18EDGAR2Form 8-K - Current report
10/20/202316:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
10/18/202307:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
10/10/202308:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..
10/05/202306:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
10/03/202306:35DJNChallenge to Novo Nordisk Obesity Drug Patents Rejected in..
10/02/202316:23EDGAR2Form 8-K - Current report
10/02/202306:01EDGAR2Form 8-K - Current report
10/01/202316:00PRNUSViatris Announces Agreements on Remaining Planned..
9/27/202307:58DJNOcuphire Shares Rally Premarket as FDA Approves Ryzumvi Eye..
9/27/202307:00PRNUSViatris and Ocuphire Pharma Announce FDA Approval of..
9/12/202313:45PRNUSViatris Named to TIME's World's Best Companies 2023 List
9/05/202304:00PRNUSViatris Announces U.S. FDA Tentative Approval of a..
8/07/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202306:38EDGAR2Form 8-K - Current report
8/07/202305:59PRNUSViatris Reports Strong Financial and Operational Results for..
8/07/202305:54PRNUSViatris and Mapi Pharma Announce FDA Acceptance of New Drug..
7/31/202305:59PRNUSViatris Announces Launch of Breyna™ (budesonide and..
7/14/202304:45PRNUSVTRS SHAREHOLDER ALERT: Jakubowitz Law Reminds Viatris..
7/12/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/07/202304:45PRNUSVTRS SHAREHOLDER ALERT: Jakubowitz Law Reminds Viatris..
7/06/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/30/202304:45PRNUSVTRS SHAREHOLDER ALERT: Jakubowitz Law Reminds Viatris..
6/28/202310:45PRNUSViatris to Report Second Quarter 2023 Financial Results on..
5/30/202308:00PRNUSViatris Named to USA Today's Inaugural List of America's..
5/22/202306:40PRNUSRobert J. Coury to Transition from Executive Chairman of..
5/22/202305:30PRNUSViatris Announces Appointment of Leo Groothuis to Company's..
5/17/202305:59PRNUSViatris to Participate in Goldman Sachs 44th Annual Global..
5/16/202308:00PRNUSViatris Publishes Sustainability Report Showcasing 2022..
5/12/202304:45PRNUSVTRS FRAUD ALERT: Jakubowitz Law is Investigating Viatris..
5/10/202304:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
5/08/202305:59PRNUSViatris Reports Strong Financial and Operational Results for..
5/05/202304:45PRNUSVTRS FRAUD ALERT: Jakubowitz Law is Investigating Viatris..
5/03/202316:23PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
4/24/202306:00PRNUSViatris and Mapi Pharma to Highlight Latest Results of..
4/19/202312:15PRNUSViatris Named in 2023 LinkedIn Top Companies List in Ireland

Your Recent History

NASDAQ
VTRS
Viatris
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com